Newly Approved Drug Therapies (380): Glyburide Tablets, Mova Pharmaceutical

Description of Medical Areas

About the FDA Approved Listings

Drugs Approved by the FDA

Drug Name: Glyburide Tablets

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Mova Pharmaceutical
Approval Status: Approved December 1997
Treatment for: blood-glucose lowering agent

General Information

Glyburide tablets have been approved as an oral blook-glucose lowering agent. It is the generic version of Pharmacia & Upjohn's Glynase PresTab.

Back to Drug Listing

Drug listing last updated on June 20, 2008

Patient Resources: [ Trial Listing ] [ Notification Services ] [ Drug Directories ]
[ About Clinical Research ] [ Patient Resources ] [ Patient Bookstore ]
Professional Resources: [ Research Center Profiles ] [ Industry Provider Profiles ] [ Jobs in Clinical Research ]
[ Industry News ] [ Professional Resources ] [ Professional Bookstore ]
General: [ Search ] [ Site Map ] [ Your Privacy ] [ CW World ] [ Home ]